|
CN110856719A
|
|
Medicinal composition of 2-aminopyrimidine compounds
|
|
CN112142677A
|
|
2-aminopyrimidine compound new crystal form VI and preparation method thereof
|
|
CN112142676A
|
|
Novel crystal form VII of 2-aminopyrimidine compound and preparation method thereof
|
|
WO2019196838A1
|
|
Pharmaceutically acceptable salt of 2-aminopyrimidine compound
|
|
CN109369552A
|
|
A kind of SC 69124 sodium novel crystal form and preparation method thereof
|
|
CN111217809A
|
|
Chiral nitrogen-containing diene ligand and preparation method and application thereof
|
|
CN109180595A
|
|
A kind of preparation method of posaconazole intermediate
|
|
CN110914267A
|
|
Pyrimidopyridone or pyridopyridone compound and application thereof
|
|
WO2018233678A1
|
|
Dexrabeprazole sodium compound and pharmaceutical composition thereof
|
|
CN108250094A
|
|
A kind of preparation method of piperazinedione compounds
|
|
CN110146601A
|
|
A kind of detection method of the palonosetron hydrochloride for injection in relation to substance
|
|
CN110117284A
|
|
Nitrogen-containing hetero cyclics and its preparation method and application
|
|
CN110041423A
|
|
A kind of renaturation and purification process of recombinant human granulocyte colony stimulating factor
|
|
CN109925283A
|
|
A kind of pharmaceutical composition of temozolomide and preparation method thereof
|
|
CN109912499A
|
|
AVM hereinafter Batan intermediate and preparation method thereof
|
|
CN109718365A
|
|
The application of recombinant human horny cell growth factor-2
|
|
CN109467527A
|
|
Tartaric acid sulfur ester and its preparation method and application
|
|
CN109400607A
|
|
AVM hereinafter Batan intermediate and preparation method thereof
|
|
CN107417626A
|
|
A kind of polymorphic forms of 2 amino-metadiazine compound
|
|
CN108619153A
|
|
Composition containing dexrazoxane and its lyophilized preparation
|
